Page last updated: 2024-11-05

zonisamide and Apnea, Obstructive Sleep

zonisamide has been researched along with Apnea, Obstructive Sleep in 2 studies

Zonisamide: A benzisoxazole and sulfonamide derivative that acts as a CALCIUM CHANNEL blocker. It is used primarily as an adjunctive antiepileptic agent for the treatment of PARTIAL SEIZURES, with or without secondary generalization.
zonisamide : A 1,2-benzoxazole compound having a sulfamoylmethyl substituent at the 3-position.

Research Excerpts

ExcerptRelevanceReference
" Zonisamide inhibits carbonic anhydrase, and induces weight loss in obese patients."5.19Zonisamide reduces obstructive sleep apnoea: a randomised placebo-controlled study. ( Eskandari, D; Grote, L; Hedner, J; Karimi, M; Stenlöf, K; Zou, D, 2014)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Eskandari, D1
Zou, D1
Karimi, M1
Stenlöf, K1
Grote, L1
Hedner, J1
Aylwin, S1
Al-Zaman, Y1

Reviews

1 review available for zonisamide and Apnea, Obstructive Sleep

ArticleYear
Emerging concepts in the medical and surgical treatment of obesity.
    Frontiers of hormone research, 2008, Volume: 36

    Topics: Adipose Tissue; Amyloid; Anticonvulsants; Antidepressive Agents; Anxiety; Appetite Regulation; Baria

2008

Trials

1 trial available for zonisamide and Apnea, Obstructive Sleep

ArticleYear
Zonisamide reduces obstructive sleep apnoea: a randomised placebo-controlled study.
    The European respiratory journal, 2014, Volume: 44, Issue:1

    Topics: Aged; Anthropometry; Body Mass Index; Body Weight; Carbonic Anhydrase Inhibitors; Carbonic Anhydrase

2014